Innoviva Inc risk profile

31 Normal where most of the sector sits

Measured 1 September 2026 from INVA's filed statements. Recomputed nightly.

31 (Normal), driven by Competitive position at 42, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation31NormalStableOne-year price volatility — 28.1%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion28NormalWorseningCash conversion — 0.73x
Leverage and coverage0ContainedEasingNet debt to EBITDA — -0.79x
Competitive position42ElevatedStableRevenue-growth gap against peers — -11.2 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Innoviva Inc